BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 23770416)

  • 21. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
    Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
    Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diabetes on biodistribution, nephrotoxicity and antitumor activity of cisplatin in mice.
    da Silva Faria MC; Santos NA; Carvalho Rodrigues MA; Rodrigues JL; Barbosa Junior F; Santos AC
    Chem Biol Interact; 2015 Mar; 229():119-31. PubMed ID: 25665769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protective effect of melatonin on cisplatin nephrotoxicity.
    Sener G; Satiroglu H; Kabasakal L; Arbak S; Oner S; Ercan F; Keyer-Uysa M
    Fundam Clin Pharmacol; 2000; 14(6):553-60. PubMed ID: 11206705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piceatannol protects against cisplatin nephrotoxicity via activation of Nrf2/HO-1 pathway and hindering NF-κB inflammatory cascade.
    Wahdan SA; Azab SS; Elsherbiny DA; El-Demerdash E
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1331-1345. PubMed ID: 31197431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
    Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
    Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity.
    Kodama A; Watanabe H; Tanaka R; Kondo M; Chuang VT; Wu Q; Endo M; Ishima Y; Fukagawa M; Otagiri M; Maruyama T
    Biochim Biophys Acta; 2014 Mar; 1840(3):1152-62. PubMed ID: 24361613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice.
    Yu YN; Chen H; Li Y
    Arch Toxicol; 2009 Apr; 83(4):381-7. PubMed ID: 18956176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity.
    Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Toxicology; 2008 Mar; 245(1-2):18-23. PubMed ID: 18243469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats.
    Trujillo J; Molina-Jijón E; Medina-Campos ON; Rodríguez-Muñoz R; Reyes JL; Loredo ML; Tapia E; Sánchez-Lozada LG; Barrera-Oviedo D; Pedraza-Chaverri J
    Toxicol Mech Methods; 2014 Oct; 24(7):520-8. PubMed ID: 25052570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
    Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
    Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of nimesulide, a cyclooxygenase-2 inhibitor, with cisplatin in normotensive and spontaneously hypertensive rats.
    Al Suleimani YM; Abdelrahman AM; AlMahruqi AS; Alhseini IS; Tageldin MH; Mansour ME; Ali BH
    Food Chem Toxicol; 2010 Jan; 48(1):139-44. PubMed ID: 19786061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice.
    Kimura T; Nojiri T; Hosoda H; Ishikane S; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Cancer Chemother Pharmacol; 2015 May; 75(5):1057-63. PubMed ID: 25814217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects.
    Malik S; Bhatia J; Suchal K; Gamad N; Dinda AK; Gupta YK; Arya DS
    Exp Toxicol Pathol; 2015; 67(7-8):427-33. PubMed ID: 26002685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
    Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
    Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-phycocyanin prevents cisplatin-induced nephrotoxicity through inhibition of oxidative stress.
    Fernández-Rojas B; Medina-Campos ON; Hernández-Pando R; Negrette-Guzmán M; Huerta-Yepez S; Pedraza-Chaverri J
    Food Funct; 2014 Mar; 5(3):480-90. PubMed ID: 24503583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymol and carvacrol prevent cisplatin-induced nephrotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats.
    El-Sayed EM; Abd-Allah AR; Mansour AM; El-Arabey AA
    J Biochem Mol Toxicol; 2015 Apr; 29(4):165-72. PubMed ID: 25487789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats.
    Dillioglugil MO; Maral Kir H; Gulkac MD; Ozon Kanli A; Ozdogan HK; Acar O; Dillioglugil O
    Urol Int; 2005; 75(4):340-4. PubMed ID: 16327303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
    Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection.
    Sahu BD; Tatireddy S; Koneru M; Borkar RM; Kumar JM; Kuncha M; Srinivas R; Shyam Sunder R; Sistla R
    Toxicol Appl Pharmacol; 2014 May; 277(1):8-20. PubMed ID: 24637089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.